作者：
Bellingan,G. [1]
;
Maksimow,M. [2]
;
Howell,D.C. [3]
;
Stotz,M. [4]
;
Beale,R. [5]
;
Beatty,M. [6]
;
Walsh,T. [7]
;
Binning,A. [8]
;
Davidson,A. [9]
;
Kuper,M. [10]
;
Shah,S. [11]
;
Cooper,J. [12]
;
Waris,M. [13]
;
Yegutkin,G.G. [14]
;
Jalkanen,J. [15]
;
Salmi,M. [16]
;
Piippo,I. ;
Jalkanen,M. ;
Montgomery,H. ;
Jalkanen,S.
作者单位：
Faron Pharmaceuticals, Turku, Finland
[1]
St Mary's Imperial College Hospital, London, United Kingdom
[2]
Royal Infirmary Edinburgh, United Kingdom
[3]
MediCity Research Laboratory, University of Turku, Finland, Department of Medical Biochemistry and
[4]
Department of Vascular Surgery, Turku University Hospital, Finland
[5]
Whittington Hospital London, United Kingdom
[6]
Victoria Infirmary Glasgow, United Kingdom
[7]
Critical Care, University College Hospital, London, United Kingdom, Department of Medicine
[8]
Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London
[9]
Department of Virology, University of Turku, Finland
[10]
MediCity Research Laboratory, University of Turku, Finland, Department of Medical Microbiology
[11]
Department of Medicine, University College London and NIHR University College London Hospitals
[12]
St Thomas's Hospital, London, United Kingdom
[13]
Critical Care, University College Hospital, London, United Kingdom
[14]
Western Infirmary Glasgow, United Kingdom
[15]
Bristol Royal Infirmary, Bristol, United Kingdom
[16]
发布时间
2014-09-04
换一批
换一批
